Brentuximab vedotin administered to platinum-refractory, transplant-naïve Hodgkin lymphoma patients can increase the proportion achieving FDG PET negative status

Normalization of fluorodeoxyglucose positron emission tomography (FDG PET) imaging prior to high-dose therapy and autologous stem cell transplantation (ASCT) improves outcomes in relapsed and refractory (RR) Hodgkin lymphoma (HL), but many patients refractory to platinum-based salvage regimens are u...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Hematol Oncol
Päätekijät: Onishi, Maika, Graf, Solomon A., Holmberg, Leona, Behnia, Sanaz, Shustov, Andrei R., Schiavo, Karen, Philip, Mary, Libby, Edward N., Cassaday, Ryan D., Pagel, John M., Roden, Jennifer E., Maloney, David G., Green, Damian J., Till, Brian G., Press, Oliver W., Smith, Stephen D., Gopal, Ajay K.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2014
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4366342/
https://ncbi.nlm.nih.gov/pubmed/25236531
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/hon.2166
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia